North America Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and Application

North America Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type and Application

  • August 2021 •
  • 116 pages •
  • Report ID: 6134369 •
  • Format: PDF
The North America biopharmaceutical tubing market is expected to reach US$ 3,090.82 million by 2028 from US$ 1,803.70 million in 2021; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

The growth of the market is attributed to some key driving factors such as increasing elderly population in world, and rising demand for minimally invasive procedures. However, stringent regulatory framework by government for biopharmaceutical applications is expected to restrict the market growth during the forecast period.

Increase in life expectancy is leading to rise in geriatric population in the world.This rise in elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems.

It is also increasing the incidence of urological conditions that require catheterization.Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI).

Aging is also a main factor that contributes to the increase in chronic diseases that might lead to the need for interventions that require admission to ICUs.Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.

Also, popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.

The North American region is highly affected due to the outbreak of the COVID-19 pandemic.The market players in North America are taking initiatives to combat the pandemic.

For instance, Saint-Gobain Life Sciences, a US-based biopharmaceutical tubing company, identified the products that can fight against COVID-19 and have given them a priority.The company placed priority on delivering orders for COVID-19 products, including single-use assemblies for the development of new vaccines and therapies as well as components for life-saving medical devices, such as ventilators and infusion pumps; thus, there is rising demand for medical devices that incorporate tubing.

Therefore, the growing demand for medical devices that incorporate tubing in North America is likely to boost the growth of the biopharmaceutical tubing market.

Based on type, the North America biopharmaceutical tubing market is segmented into plastic, metal, and silicone. The silicone segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Based on application, the North America biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources associated with this report on the North America biopharmaceutical tubing market are the Centers for Disease Control and Prevention (CDC), Organization for Economic Co-operation and Development (OECD), and Food and Drug Administration (FDA).
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.